Combined systemic beta-interferon and thymostimulin administration for metastatic brain tumors. A brief report.
Department of Neurosurgery, Faculty of Medicine, University of Messina, Italy.Journal of neurosurgical sciences (Impact Factor: 1.16). 04/1994; 38(1):35-42.
Interferon-beta (IFN-B) plus thymostimulin (Th) were administered for eight weeks, intravenously and by intramuscular route to eight patients with metastatic brain tumors. No patient had a complete response. One had a stable disease and seven a progressive disease during that time. The mechanisms of the action of IFN-B and Th, and the possible therapeutic value are discussed.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.